Over the last 10 years, the incidence of chronic pancreatitis (CP) has increased 4 times and nowadays is about 27.450 cases per 100 000 adults. In the outpatient gastroenterologist practice, patients with CP account for about 3545%, in the hospital gastroenterology department up to 2045%. CP criteria according to imaging methods fibrosis, duct dilatation and deformation, calcifications in the pancreatic parenchyma or its atrophy are formed at a late stage of the disease. Simultaneously, diagnosis at the early stage with potentially reversible changes remains difficult, due to the lack of clear instrumental and laboratory findings confirming minimal changes in the pancreas. However, some methods in combination with a detailed history taking, risk factors identification in comparison with the clinical features are of interest for the early diagnosis of chronic pancreatitis.
Liver cirrhosis is a disease gastroenterologists and therapists face daily, and not only in the hospital when it comes to treating complications, but also at outpatient appointments, when the disease is in the compensation stage. At the same time, in the age group of 20–40 years, mortality from liver cirrhosis (LC) exceeds that from coronary heart disease. Despite modern advances in intensive care and transplantation, the mortality rate in the development of liver failure remains high [1]. For example, in 2015, there were 1.3 million deaths from liver cirrhosis, of which 348,000 were caused by alcohol, 326,000 by hepatitis C, and 371,000 by hepatitis B [2]. The classic manifestations of cirrhosis leave no doubt in the diagnosis, however, a detailed history taking, active identification of risk factors at the stage of the latent course of liver cirrhosis can prevent many severe complications of this disease and reduce the number of hospitalizations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.